Research Experience

Survey of Dermatopathology Exposure in Dermatology and Pathology Residency Programs: An Updated Analysis

(January 2025 - present)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

• Surveyed dermatology and pathology program directors of accredited programs to assess current dermatopathology training structures, didactic curricula, and clinical exposure.

Evaluating the Performance of ChatGPT on Dermatology Board-Style Exams: A Meta-Analysis of Text-Based and Image-Based Question Accuracy

(January 2025 – February 2025)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

• Meta-analysis examining ChatGPT’s performance (GPT-3.5 and GPT-4) on dermatology board-style questions, including both text-based and image-based items.

Characterizing a Novel Medical Student-Focused Dermatology Research Initiative: A Comprehensive Analysis of the Brigham and Women’s Hospital Dermatologic Symposium (2021–2024)

(January 2025 – February 2025)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

• Retrospective study assessing the demographics and sentiment of previous participants of the Brigham and Women’s Hospital Dermatology Medical Student Research Symposium.

Evaluating the Role of C-Reactive Protein in Guiding Antibiotic and Corticosteroid Management in Hospitalized Hidradenitis Suppurativa Patients: A Retrospective Cohort Study

(November 2024 – present)

Department of Dermatology, Beth Israel Deaconess Medical Center

PI: Christopher Iriarte, MD

• Single-institution retrospective study assessing C-reactive protein levels in hospitalized hidradenitis suppurativa patients and whether this marker may be used to guide antibiotic and corticosteroid management and de-escalation.

VEXAS Syndrome: A Clinical Review of an Emerging Autoinflammatory Disorder

(November 2024 - December 2024)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

• Invited clinical review from Clinics in Dermatology focusing on the pathophysiology, dermatologic manifestations, and management strategies of VEXAS syndrome.

Evaluating the Accuracy of Large Language Models in Predicting ICD-10 and CPT Billing Codes for Outpatient Dermatology Notes

(November 2024 – present)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

Utilized the API of 5 LLMs to test their respective ability to correctly assign ICD-10 and CPT codes to 8 standardized outpatient dermatology progress notes.

Carcinoma en Cuirasse is an Independent Poor Survival Predictor in Breast Carcinoma Patients with Cutaneous Metastasis

(November 2024 - February 2025)

Department of Pathology, Massachusetts General Hospital

PI: Mai Hoang, MD

• Retrospective study identifying clinicopathologic factors that influence survival outcomes in breast carcinoma patients with cutaneous metastases.

Psoriasis in the Era of Targeted Cancer Therapeutics: A Systematic Review on De Novo and Pre-existing Psoriasis in Oncologic Patients Treated with Emerging Anti-neoplastic Agents

(December 2023 – January 2024)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD, MBA, EdM

• Invited review analyzing the impact of targeted cancer therapies on de novo and pre-existing psoriasis in oncology patients, focusing on mechanisms and management of drug-induced psoriasis.

Representation of Skin Tone and Sex in Dermatology by Generative Artificial Intelligence

(December 2023 – Present)

Department of Dermatology, Brigham and Women’s Hospital

PI: Vinod Nambudiri, MD

• Utilized AI platforms to generate images for the eight most common dermatologic conditions identified by the AAD.

• Assessed the inclusivity of images by identifying sex-determination characteristics and evaluating skin tone via the Massey-Martin skin color scale.

Use of Artificial Intelligence in the Assessment of Skin Conditions

(October 2023 – Present)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Nikki Levin, MD, PhD

• Assessed the ability of AI chatbot platforms and consumer smartphone applications for their accuracy in identifying problematic skin lesions and offering appropriate clinical advice based on image prompts.

Racial Disparities in Melanoma Survival Outcomes

(June 2023 – Present)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Bassel H. Mahmoud, MD, PhD

• Reviewed three large databases (NCI SEER, CDC NPCR, NIH All of Us) to determine survival outcomes across diverse patient populations and demographics.

Melanocyte Colonization and Pigmentation of Breast Carcinoma: Case Report and Literature Review

(April 2023 – Present)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Patrick O’Donnell, DO

• Dermatopathology case report discussing the rare phenomenon of benign melanocytic colonization in advanced breast carcinoma.

Use of an Artificial Intelligence Chatbot to Interpret Dermatopathology Reports in Simple Language

(March 2023 – Present)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Nikki Levin, MD, PhD

• Utilized ChatGPT to simplify complex dermatopathology reports.

• Coordinated with dermatology and dermatopathology faculty and residents to evaluate translations based on accuracy, completeness, and reliability.

The Chatbots are Coming: Risks and Benefits of Consumer-Facing Artificial Intelligence in Clinical Dermatology

(February 2023 – March 2023)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Nikki Levin, MD, PhD

• Investigated the potential application of AI chatbots in dermatology for translating medical information and providing differential diagnoses.

• Recognized limitations in chatbot training data and accuracy, emphasizing the need for further research and validation.

Utilizing Laser Capture Microdissection-Directed Whole Genome Sequencing for Urothelial Carcinoma Surveillance  

(June 2022 – Present)                                                

Department of Pathology, University of Massachusetts Chan Medical School

PI: Andrew Fischer, MD

• Participated in the Research, Community, and Curriculum Exploration Summer Program (RCCE).

• Developed a novel screening method for urothelial carcinoma using laser capture to isolate cells of interest from urine cytology samples.

• Optimized DNA amplification protocol to enable accurate analysis of small cell counts (1 cell).

Novel Method for Time-Lapse Ex Vivo Microscopy of Human Tissue Discloses Nuclear Rotation and Other Unexpected Dynamics          

(June 2022 – Present)            

Department of Pathology, University of Massachusetts Chan Medical School

PI: Andrew Fischer, MD

• Developed a platform for observing live intact human tissue under microscopy.

• Identified a distinct “nuclear rolling” dynamic in live cell nuclei, exhibiting variation between normal and cancerous tissue.

Mechanical Stimulation Improves Functional Recovery after Skeletal Muscle Injury

(April 2022 – May 2023)       

Department of Plastic Surgery, University of Massachusetts Chan Medical School

PI: Giorgio Giatsidis, MD, PhD

• Developed a novel rehabilitative therapy that adopts non-invasive, external mechanical stimulation to enhance the recovery of muscles after volumetric muscle loss injury in rat and swine models.

Wound Care Adherence in Mohs Micrographic Surgery: A Prospective Cohort Study   

(April 2022 – January 2023)

Department of Dermatology, University of Massachusetts Chan Medical School

PI: Bassel H. Mahmoud, MD, PhD

• Implemented a modified MMAS-8 survey to assess wound care habits and postoperative outcomes in Mohs micrographic surgery patients.

Combined Dermatology and Clinical Research Post-Baccalaureate Premedical Fellowship at Dermcare Experts and Beacon Clinical Research (Quincy MA)

PI: Victoria Kuohung, JD, MD

Clinical Research Coordinator Level I (June 2019 – July 2021) for the following studies:                      

o   Fibromyalgia Phase II Study

o   Atopic Dermatitis Phase II Study

Laboratory of Cancer Pharmacogenomics, Boston University School of Medicine

Undergraduate Research Assistant (August 2017 - March 2019)

PI: Anurag Singh, PhD

Oak Ridge National Laboratory (Grand Rapids, MN)

Undergraduate Research Assistant (May 2017 – August 2017)